EDITORIAL
Published on 24 Nov 2022
Editorial: Cytoskeleton in the focus of anti-cancer therapy: In a search of novel biomarkers and combinatorial therapy approaches
doi 10.3389/fphar.2022.1069821
- 1,264 views
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Cytoskeletal Components as Biomarkers and Targets for Anti-Cancer Therapy: How Treatment of the Cytoskeleton can Inhibit Tumor Progression
Cytoskeletal Components as Biomarkers and Targets for Anti-Cancer Therapy: How Treatment of the Cytoskeleton can Inhibit Tumor Progression
7,576
Total downloads
31k
Total views and downloads
Articles
REVIEW
Published on 10 Oct 2022
Cancer cells can be killed mechanically or with combinations of cytoskeletal inhibitors
doi 10.3389/fphar.2022.955595
- 4,216 views
- 4 citations
REVIEW
Published on 06 Oct 2022
How does plasticity of migration help tumor cells to avoid treatment: Cytoskeletal regulators and potential markers
doi 10.3389/fphar.2022.962652
- 1,769 views
- 6 citations
ORIGINAL RESEARCH
Published on 15 Sep 2022
Bcl-xL activity influences outcome of the mitotic arrest
doi 10.3389/fphar.2022.933112
- 2,666 views
- 8 citations
REVIEW
Published on 15 Sep 2022
The microtubule cytoskeleton: An old validated target for novel therapeutic drugs
doi 10.3389/fphar.2022.969183
- 5,160 views
- 26 citations
REVIEW
Published on 14 Sep 2022
Emerging role of microtubule-associated proteins on cancer metastasis
doi 10.3389/fphar.2022.935493
- 5,734 views
- 33 citations
ORIGINAL RESEARCH
Published on 30 May 2022
Synthesis, Screening and Characterization of Novel Potent Arp2/3 Inhibitory Compounds Analogous to CK-666
doi 10.3389/fphar.2022.896994
- 3,431 views
- 8 citations
MINI REVIEW
Published on 26 May 2022
Cytoplasmic Beta and Gamma Actin Isoforms Reorganization and Regulation in Tumor Cells in Culture and Tissue
doi 10.3389/fphar.2022.895703
- 3,154 views
- 11 citations
Published in
Frontiers in Pharmacology
Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore